Evrofarma SA (ATH:EVROF)
Greece · Delayed Price · Currency is EUR 4.050
+0.030 (0.75%)
Nov 12, 2026, 5:09 PM EET
| Market Cap | 55.34M +49.3% |
| Revenue (ttm) | 51.59M +6.6% |
| Net Income | 4.32M +60.7% |
| EPS | 0.32 +60.7% |
| Shares Out | 13.66M |
| PE Ratio | 12.81 |
| Forward PE | n/a |
| Dividend | 0.06 (1.48%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 4,464 |
| Open | 4.060 |
| Previous Close | 4.020 |
| Day's Range | 3.910 - 4.060 |
| 52-Week Range | 2.690 - 4.370 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 23, 2026 |